- Conditions
- Obstructive Sleep Apnea
- Interventions
- 8mg dexamethasone
- Drug
- Lead sponsor
- Medical University of South Carolina
- Other
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026
- U.S. locations
- 1
- States / cities
- Charleston, South Carolina
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1537–1560
of 1,797
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Mohs Micrographic Surgery, Excision Margin
- Interventions
- Timolol 0.5% Ophthalmic Solution, Hydrogel of placebo
- Drug · Other
- Lead sponsor
- University of California, Davis
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 220 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 2
- States / cities
- Sacramento, California
- Conditions
- Schizophrenia, Schizophreniform Disorder
- Interventions
- Citalopram, Placebo, Psychoeducation, Cognitive Behavioral Therapy (CBT), Functional Magnetic Resonance Imaging (fMRI)
- Drug · Behavioral · Radiation
- Lead sponsor
- NYU Langone Health
- Other
- Eligibility
- 16 Years to 40 Years
- Enrollment
- 95 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2018
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Necrotizing Enterocolitis
- Interventions
- Remote ischemic conditioning (RIC) + Standard of Care for NEC, Standard of Care for NEC
- Other
- Lead sponsor
- The Hospital for Sick Children
- Other
- Eligibility
- 0 Weeks and older
- Enrollment
- 86 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 1
- States / cities
- Cincinnati, Ohio
- Conditions
- HIV, Aging
- Interventions
- transcranial direct current stimulation (tDCS)
- Device
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 50 Years and older
- Enrollment
- 42 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2016
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
- Conditions
- Marijuana Abuse
- Interventions
- Tetrahydrocannabinol
- Drug
- Lead sponsor
- Wayne State University
- Other
- Eligibility
- 21 Years to 45 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2005 – 2009
- U.S. locations
- 1
- States / cities
- Detroit, Michigan
- Conditions
- Peripheral Arterial Disease
- Interventions
- Pro-Omega, Pro-Omega Placebo
- Dietary Supplement · Other
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 40 Years to 90 Years
- Enrollment
- 8 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2017
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- MN-221, Placebo
- Drug
- Lead sponsor
- MediciNova
- Industry
- Eligibility
- 40 Years to 75 Years
- Enrollment
- 19 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012
- U.S. locations
- 2
- States / cities
- New Braunfels, Texas • San Antonio, Texas
- Conditions
- Pre-diabetes, Obesity
- Interventions
- Mirabegron 50 MG, Tadalafil 10 MG, Placebo
- Drug
- Lead sponsor
- Philip Kern
- Other
- Eligibility
- 35 Years to 65 Years
- Enrollment
- 96 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2027
- U.S. locations
- 1
- States / cities
- Lexington, Kentucky
- Conditions
- Alcohol Use Disorder, Alcohol Drinking, Substance Use, Drinking, Alcohol, Alcohol Use Disorder (AUD)
- Interventions
- Real TBS to the mPFC, Sham TBS to the mPFC
- Device
- Lead sponsor
- Medical University of South Carolina
- Other
- Eligibility
- 21 Years to 65 Years
- Enrollment
- 86 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2026
- U.S. locations
- 1
- States / cities
- Charleston, South Carolina
- Conditions
- NSAID (Non-Steroidal Anti-Inflammatory Drug), Lumbar Spine Fusion, Ketorolac, Postoperative Pain
- Interventions
- Ketorolac, Naproxen, Standard Postoperative Pain Management
- Drug · Other
- Lead sponsor
- Rothman Institute Orthopaedics
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 428 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2028
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Staphylococcal Infections
- Interventions
- SA4Ag vaccine low dose, Blood draw, Colonization swab sample, SA4Ag vaccine mid dose, Blood sample, SA4Ag vaccine high dose, Placebo
- Biological · Procedure
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 64 Years
- Enrollment
- 456 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011 – 2013
- U.S. locations
- 16
- States / cities
- Hollywood, Florida • South Miami, Florida • Overland Park, Kansas + 10 more
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- Pioglitazone, Placebo, Pancreatic Clamp Study
- Drug · Procedure
- Lead sponsor
- Albert Einstein College of Medicine
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 26 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2000 – 2011
- U.S. locations
- 1
- States / cities
- The Bronx, New York
- Conditions
- Obesity
- Interventions
- ACCG-2671, Placebo
- Drug
- Lead sponsor
- Aconcagua Bio, Inc. a wholly owned subsidiary of Structure Therapeutics
- Industry
- Eligibility
- 25 Years to 75 Years
- Enrollment
- 164 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2027
- U.S. locations
- 6
- States / cities
- Cypress, California • Lake Forest, California • Decatur, Georgia + 3 more
- Conditions
- Central Retinal Artery Occlusion
- Interventions
- KUS121 high dose, KUS121 low dose, Sham procedure
- Drug
- Lead sponsor
- Kyoto Drug Discovery and Development Co., Ltd.
- Industry
- Eligibility
- 20 Years and older
- Enrollment
- 17 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2025
- U.S. locations
- 11
- States / cities
- Encino, California • Huntington Beach, California • Oakland, California + 8 more
- Conditions
- Stress, Burnout, Professional, Stress, Job
- Interventions
- Herbaceous Essential Oil Blend, Citrus Essential Oil Blend, Inert Oil
- Other
- Lead sponsor
- Nutraceuticals Research Institute
- Other
- Eligibility
- 20 Years to 59 Years
- Enrollment
- 114 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- Franklin, Tennessee
- Conditions
- Nicotine Dependence
- Interventions
- Varenicline
- Drug
- Lead sponsor
- University of Pennsylvania
- Other
- Eligibility
- 21 Years to 65 Years
- Enrollment
- 48 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2010
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Sleep Apnea, Sleep Apnea, Obstructive
- Interventions
- Oxytocin, Placebo
- Drug
- Lead sponsor
- Vivek Jain
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2026
- U.S. locations
- 1
- States / cities
- Washington D.C., District of Columbia
- Conditions
- Opioid-use Disorder, Substance Use Disorders
- Interventions
- Exablate Model 4000 Type 2.0/2.1
- Device
- Lead sponsor
- InSightec
- Industry
- Eligibility
- 18 Years to 60 Years
- Enrollment
- 29 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2027
- U.S. locations
- 4
- States / cities
- Tampa, Florida • Baltimore, Maryland • New York, New York + 1 more
- Conditions
- Emphysema, COPD
- Interventions
- IBV® Valve System
- Device
- Lead sponsor
- Olympus Corporation of the Americas
- Industry
- Eligibility
- 40 Years to 74 Years
- Enrollment
- 277 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2017
- U.S. locations
- 34
- States / cities
- Birmingham, Alabama • Los Angeles, California • Mission Viejo, California + 29 more
- Conditions
- Advanced Cancer, Fatigue
- Interventions
- Methylphenidate, Nursing Telephone Intervention, Placebo, Non NTI
- Drug · Behavioral
- Lead sponsor
- M.D. Anderson Cancer Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 197 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2021
- U.S. locations
- 2
- States / cities
- Houston, Texas
- Conditions
- Diabetes
- Interventions
- Oral Glucose Tolerance Test
- Procedure
- Lead sponsor
- University of Maryland, Baltimore
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 400 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2032
- U.S. locations
- 1
- States / cities
- Lancaster, Pennsylvania
- Conditions
- Healthy
- Interventions
- Active Comparator: Sitagliptin, Placebo Comparator - No Sitagliptin
- Drug
- Lead sponsor
- David D'Alessio, M.D.
- Other
- Eligibility
- 35 Years to 70 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2018
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
- Conditions
- End Stage Renal Disease Requiring Hemodialysis
- Interventions
- Fesomersen sodium (BAY2976217), Placebo
- Drug
- Lead sponsor
- Bayer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 307 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2022
- U.S. locations
- 9
- States / cities
- Clovis, California • Victorville, California • Fort Lauderdale, Florida + 5 more